Dianthus Therapeutics Inc. logo

Dianthus Therapeutics Inc. (DNTH)

Market Closed
1 Sep, 20:00
NASDAQ (CM) NASDAQ (CM)
$
106. 62
+1.01
+0.9563%
$
5.92B Market Cap
- P/E Ratio
- Div Yield
576,598 Volume
-6.17 Eps
$ 105.61
Previous Close
Add Transaction
Day Range
104.65 107.52
Year Range
23.39 117.88
Want to track DNTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Dianthus Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
SummitTX Capital LP
SummitTX Capital LP SummitTX Capital LP
63,866 $3.15M $7.41M $4.26M 135.15%
BCG
BIT Capital GmbH BIT Capital GmbH
12,000 $494,520 $1.35M $854,400 172.77%
Samira Kadam
Samira Kadam Synergy Investment Management LLC
13 $1,243.84 $1,507.48 $263.64 21.2%
BM
Berkeley Meredith Hughes Financial Services LLC
3 $252 $320.76 $68.76 27.29%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
5,571 $229,580.8 $606,793.32 $377,212.52 164.3%
RFL
Rossby Financial LLC Rossby Financial LLC
57 $4,820 $6,094.44 $1,274.44 26.44%
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
48,609 $3.7M $5.34M $1.64M 44.39%
Ameriflex Group Inc.
Ameriflex Group Inc. Ameriflex Group Inc.
29 $2,827 $3,362.84 $535.84 18.95%
Nicole Reese
Nicole Reese WPG Advisers LLC
251 $21,809.29 $27,584.9 $5,775.61 26.48%